Tue, January 9, 2018
Mon, January 8, 2018
Fri, January 5, 2018
Thu, January 4, 2018
Wed, January 3, 2018

Madhu Kumar Initiated (ABUS) at Strong Buy and Held Target at $10 on, Jan 5th, 2018

Madhu Kumar of B. Riley Securities, Initiated "Arbutus Biopharma Corporation" (ABUS) at Strong Buy and Held Target at $10 on, Jan 5th, 2018.

Madhu has made no other calls on ABUS in the last 4 months.



There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, all agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Maintained at Hold with Increased Target to $5.5 on, Tuesday, November 7th, 2017